Favipiravir is an antiviral used to manage influenza, and that has the potential to target other viral infections.
In 2014, favipiravir was approved in Japan to treat cases of influenza that were unresponsive to conventional treatment. Given its efficacy at targetting several strains of influenza, it has been investigated in other countries to treat novel viruses including Ebola and most recently, COVID-19
Dosage:
The recommended dosage of Favipiravir for adults is usually 1,800 mg (four 450 mg tablets) twice a day on the first day, followed by 800 mg (two 400 mg tablets) twice a day for the next 10 days. However, this may vary based on the severity of the infection and the prescribing physician's discretion.
Content
Tab 200mg: Favipiravir 200mg
Pregnancy
Consult With Your Doctor
Stability
Antiviral Agent
Contra Indications
It is not appropriate for everyone, and there are some contraindications to its use. Favipiravir should not be used by pregnant women, as it has been shown to cause harm to develop fetuses in animal studies. Additionally, it is not recommended for people with severe renal impairment or those with an end-stage renal disease requiring dialysis. People with a history of hypersensitivity to favipiravir or any of its components should also avoid its use.
Precautions
It is not appropriate for everyone, and there are some contraindications to its use. Favipiravir should not be used by pregnant women, as it has been shown to cause harm to develop fetuses in animal studies. Additionally, it is not recommended for people with severe renal impairment or those with an end-stage renal disease requiring dialysis. People with a history of hypersensitivity to favipiravir or any of its components should also avoid its use.
Lactation
Consult With Your Doctor
Side Effects
Gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal pain
Headache
Elevated liver enzymes
Skin rash
Increased risk of bacterial infections
Reduction in white blood cell count (neutropenia)
Elevated uric acid levels
Teratogenic effects (potential harm to a developing fetus)